2004 Chrysler Sebring Touring Convertible Florida Clean! on 2040-cars

Auto blog

Dodge Challenger spied exercising supercharged Hellcat Hemi V8

One of the prime complaints against the Dodge Challenger is that, even in SRT8 guise, its 470 horsepower is responsible for hauling over 4,200 pounds of vehicle. For comparison, the 420 hp in the Ford Mustang GT only has to deal with 3,618 lbs. Things only get worse from there, as the higher-performance variants of both the Mustang and the Chevrolet Camaro are far more powerful than an SRT8 without adding on much heft.
So what is Chrysler to do? The correct answer is add a whole lot more grunt to its hefty two-door and even the odds. That's where the all-new Hellcat engine comes into play. We reported on this engine in May, and suggested that the Hellcat, a supercharged powerplant based on a 6.4-liter V8, would easily generate 500 to 570 hp and could likely arrive boasting more than 600 ponies.
Chrysler's ace in its sleeve has now been spied testing, with a number of Hellcat-equipped Challengers running the potent new engine both in more urbanized areas and under the sun of Death Valley. The hoods on these testers have been raised to accommodate the engine, and that camouflage over the fascias of these prototypes is there to hide a larger air intake. We also note what appears to be a new split grille under wraps. As for power output, our spies are now suggesting a Viper-equalling 640 hp from the Hellcat-equipped cars.

Stellantis, GM pay $363 million in U.S. fuel economy penalties

WASHINGTON — Stellantis and General Motors paid a total of $363 million in civil penalties for failing to meet U.S. fuel economy requirements for prior model years, documents seen on Friday by Reuters show. The record-setting penalties include $235.5 million for Stellantis for the 2018 and 2019 model years and $128.2 million for GM covering 2016 and 2017, according to the National Highway Traffic Safety Administration (NHTSA), which administers the Corporate Average Fuel Economy (CAFE) program. Stellantis — which also owns Fiat, Peugeot and other marques — said the penalty "reflects past performance recorded before the formation of Stellantis, and is not indicative of the companyÂ’s direction." Stellantis previously paid a total of $156.6 million in penalties for the 2016 and 2017 model years. GM said Friday as "we work towards the goal of a zero-emissions future, we may use a combination of credits from prior model years, expected credits from future model years, credits obtained from other manufacturers, and payment of civil penalties to comply with increasingly stringent CAFE regulations." GM, which sells Chevrolet, Buick, GMC and Cadillac vehicles in the U.S., had not previously paid a fine in the 40-year history of the CAFE program. It had initially planned to use credits to meet its compliance shortfall but opted to pay penalties, NHTSA said. The GM and Stellantis penalties were paid between December and May, according to the records. This is the first time in three years the agency has collected fuel economy penalties. NHTSA in April 2022 said it calculated there would be 11 instances between 2018 and 2021 "where substantial civil penalty payments will have to be made," but did not disclose the automakers involved. The disclosure comes ahead of NHTSA's plan to soon propose more stringent fuel economy standards for 2027 and beyond, after the Environmental Protection Agency in April proposed a 56% reduction in projected fleet average emissions over 2026 requirements by 2032. Sharp increase The EPA said in December Stellantis had the lowest real-world fuel economy among all major automakers, at 21.3 miles per gallon on average in 2021, while GM was second-lowest at 21.6 mpg. In March 2022, NHTSA reinstated a sharp increase in penalties for automakers whose vehicles do not meet fuel efficiency requirements for 2019 and beyond.

Fiat Chrysler says it did not know about Marchionne's illness

ZURICH/MILAN — Fiat Chrysler said it knew nothing about the medical condition of Sergio Marchionne after a Swiss hospital said on Thursday it had been treating the deceased chief executive for more than a year. "Due to medical privacy, the company had no knowledge of the facts relating to Mr. Marchionne's health," a Fiat Chrysler spokesman said. Questions have been raised about how long Marchionne, who died on Wednesday, was ill and how much the company knew before it made the situation public. Marchionne rescued Fiat and Chrysler from bankruptcy after taking the wheel of the Italian carmaker in 2004 and he multiplied Fiat's value 11 times through 14 years of canny dealmaking. He was due to step down at FCA in April next year. "The company was made aware that Mr. Marchionne had undergone shoulder surgery and released a statement about this," the spokesperson said. "On Friday, July 20, the company was made aware with no detail by Mr. Marchionne's family of the serious deterioration in Mr. Marchionne's condition and that as a result he would be unable to return to work. The company promptly took and announced the appropriate action the following day." Asked whether the scope of the statement included the board and the chairman, the company declined to comment. In emailed comments, Marchionne's family confirmed the companies had not been aware of his health conditions. "At the end of last week FCA was made aware Sergio Marchionne would no longer be able to return to work without mentioning any further details," the family said. The announcement of the death of Marchionne, 66, one of the auto industry's most tenacious and respected CEOs, drew tributes from rivals and tears from his closest colleagues on Wednesday. University Hospital Zurich said earlier on Thursday Marchionne had been treated for a serious illness for more than a year before his death. Marchionne had fallen gravely ill after what the company had described as shoulder surgery at a Zurich hospital. He was replaced as chief executive last weekend after Fiat Chrysler (FCA) said his condition had worsened. "Mr. Sergio Marchionne was a patient at USZ. Due to serious illness, he had been the recipient of recurring treatment for more than a year," the hospital said in a statement. "Although all the options offered by cutting-edge medicine were utilized, Mr.